Disposable Endoscopes Market

The global disposable endoscopes market is projected to reach USD 2.67 billion by 2030, growing from USD  0.95 billion in 2025, at a CAGR of 22.9% during the forecast period.

The disposable endoscopes market is expanding due to increasing demand for minimally invasive procedures, a rising prevalence of chronic diseases such as neurological and respiratory disorders, and technological advancements that improve image quality and maneuverability. Additionally, the growing geriatric population and better reimbursement policies further encourage adoption. However, market growth is limited by high device costs, the risk of cross-contamination despite reprocessing, and the availability of alternative diagnostic techniques.

Some of the key players in the disposable endoscopes market with a significant global presence include Olympus Corporation (Japan), Ambu A/S (Denmark), Boston Scientific Corporation (US), Hoya Corporation (Japan), Verathon Inc., a Roper Technologies Company (US), KARL STORZ SE & Co. KG (Germany), Innovex Medical Co., Ltd. (China), Hunan Vathin Medical Instrument Co., Ltd. (China), and others. These companies implement various organic and inorganic growth strategies, such as acquisitions, new product launches, product approvals, and partnerships, to strengthen their international presence and increase their share in the disposable endoscopes market. These strategies enable market players to expand across different regions by offering disposable endoscopes products.

To know about the assumptions considered for the study download the pdf brochure

In June 2025, Ambu announced that the US Food and Drug Administration (FDA) had granted expanded 510(k) clearance for its aScope 5 Cysto HD, extending its approved uses to include use in percutaneous nephrolithotomy (PCNL) procedures.

In May 2025, Ambu launched additional sizes of video laryngoscope blades for the new Ambu SureSight Connect video laryngoscopy solution.

In February 2025, Ambu announced the expansion of its European regulatory approval (CE mark) for the Ambu aScope 5 Cysto HD. This allows the platform to function as a single-use flexible cysto-nephroscopy solution and enter a new niche procedure segment in urology.

In April 2025, KARL STORZ announced the launch of the Slimline C-MAC S single-use video laryngoscope, designed for high-performance airway management. The device provides improved visualization for reliable intubation, even in complex clinical situations, while maintaining the company’s well-known quality standards.

In January 2025, KARL STORZ SE & Co. KG (Germany) announced the strategic acquisition of its longstanding Swiss distributor, ANKLIN, to strengthen its direct sales presence in Switzerland. This move improved customer proximity and supported its tailored product and service delivery in the MedTech sector.

Ambu A/S (Denmark)

Ambu A/S is a leading player in the global disposable endoscopes market due to its strong product lineup, ongoing innovation, and strategic regulatory progress. The company offers a broad range of single-use endoscopes for pulmonary, gastrointestinal, urology, and ENT applications, meeting diverse clinical needs across multiple specialties. Ambu’s consistent focus on organic growth, including new product launches and regulatory approvals, has reinforced its market leadership. For example, in June 2025, the company received expanded FDA 510(k) clearance for the Ambu® aScope™ 5 Cysto HD, boosting its position in the urology segment. With significant operational strength and a commercial presence across North America and Europe, Ambu has built a solid customer base and strong brand recognition in key healthcare markets. Its dedication to infection control, clinical efficiency, and performance-driven design continues to make it a preferred partner for hospitals and healthcare providers moving toward single-use endoscopes.

Boston Scientific Corporation (US)

Boston Scientific Corporation is a leading player in the global disposable endoscopes market thanks to its extensive international presence, advanced technology, and diverse product range. The company offers high-performance single-use endoscopes for urology and gastroenterology, meeting the rising clinical demand for infection control, cost savings, and better patient outcomes. By utilizing its widespread distribution network and strong relationships with healthcare providers worldwide, Boston Scientific guarantees broad access and uptake of its disposable endoscopic solutions. Continued investments in innovation, research, and product development allow the company to deliver superior imaging, maneuverability, and reliability, meeting the changing needs of physicians. Additionally, its solid regulatory expertise and focus on expanding its portfolio bolster its competitive edge in both mature and emerging markets. Through its dedication to quality, innovation, and a global footprint, Boston Scientific maintains a leading position in driving the shift toward single-use endoscopes.

Market Ranking

The ranking of firms in the disposable endoscopes market is determined through market share analysis, secondary research, and validation from primary respondents. This rating considers revenue from the breadth and depth of the product portfolio, innovation, and approvals or launches. The disposable endoscopes market is consolidated, with five main players, Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Boston Scientific Corporation (US), HOYA Corporation (Japan), and Ambu A/S (Denmark) together hold over 50% of the total market share. Olympus Corporation (Japan) remains a leader thanks to its extensive and diverse range of disposable endoscopes used across various surgical specialties, expanding its global presence. Ambu A/S (Denmark) is a key player with a wide selection of disposable endoscopes for applications such as urology, gastroenterology, and more. HOYA Corporation (Japan) and Boston Scientific Corporation (US) leverage their strong international presence to serve multiple therapeutic areas, ensuring broad market reach and better customer access. These companies prioritize technological innovation, product differentiation, and strategic partnerships to stay competitive and meet the changing needs of healthcare providers. Overall, the main players in the disposable endoscopes market focus on expanding their product offerings, increasing their global reach, and pursuing strategic initiatives to meet growing demand in surgical applications, maintaining market leadership in a competitive, technology-driven healthcare environment.

Related Reports:

Disposable Endoscopes Market by Type (GI Endoscopes, Urology Endoscopes, Laryngoscopes), Clinical Usage (Diagnostic, Surgical), Application (Urology, Gastroenterology, ENT Endoscopy), End User (Hospitals, ASCs, Clinics), Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com